IMMUNOCLIN
DEAD

Add to watchlist:

No watchlists yet
View on USPTO

IMMUNOCLIN Trademark

Serial Number: 76975136 • Registration: 3037460

IMMUNOCLIN is a trademark filed by Immunoclin Laboratories Limited on June 29, 2000. The trademark is classified under Class 1 (Chemicals), Class 5 (Pharmaceuticals), Class 41 (Education & Entertainment), Class 42 (Computer & Scientific). The application is currently no longer active.

Owner Contact Info

Immunoclin Laboratories Limited (2 trademarks)

Ian Cobden 289-293 Ballards Lane
London N12 8NP , GB

Entity Type: 11

IMMUNOCLIN LIMITED (2 trademarks)

289-293 BALLARDS LANE
LONDON N12 8NP , GB

Entity Type: 03

Trademark Details

Filing Date

June 29, 2000

Registration Date

January 3, 2006

Published for Opposition

June 3, 2003

Cancellation Date

August 10, 2012

Goods & Services

Education services, namely, conducting face-to-face and on-line real-time classes, seminars, conferences and workshops among patients and physicians and providing information related thereto in the field of immunology and prevention and clinical management of diseases that require modulation of the immune systems, and distributing course materials in connection therewith; development and dissemination of educational materials of others in the field of immunology and prevention and clinical management of diseases that require modulation of the immune system

Pharmaceutical preparations for use in the diagnosis and treatment of immune system deficiencies and diseases involving the immune system, namely, transplant rejection, rheumatoid arthritis, cancers, myalgic encephalomyelitis (ME), chronic fatigue syndrome (CFS) chronic fatigue and immune dysfunction syndrome (CFIDS), fibromyalgia syndrome (FMS), multiple sclerosis (MS), HIV/AIDs, hepatitis, and human papilloma virus; chemical preparations for testing blood for medical purposes and diagnostic and testing materials for medical use, namely, diagnostic reagents for clinical or medical laboratory use; vaccines and sera containing antibodies; pharmaceutical preparations for treatment of immune system deficiencies, namely, protein chips and/or biological assays such as enzyme-linked immunosorbent assay (ELISA)

CHEMICAL PREPARATIONS FOR TESTING BLOOD FOR SCIENTIFIC USE

Performing a combination of predictive medical tests, compiling and presenting results of said tests by way of comparable numeric data where results data are presented in a graph against a background and rising scale of known values which enables immediate visual comparison and interpretation of individual test services results against existing data

Filing History

CANCELLED SEC. 8 (6-YR)
Aug 10, 2012 C8..
REGISTERED-PRINCIPAL REGISTER
Jan 3, 2006 R.PR
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Dec 6, 2004 TCCA
OPPOSITION TERMINATED NO. 999999
Aug 10, 2004 OP.T
OPPOSITION TERMINATED NO. 999999
Aug 10, 2004 OP.T
OPPOSITION DISMISSED NO. 999999
Aug 4, 2004 OP.D
OPPOSITION INSTITUTED NO. 999999
Oct 28, 2003 OP.I
EXTENSION OF TIME TO OPPOSE RECEIVED
Jul 16, 2003 ETOF
PAPER RECEIVED
Jul 2, 2003 MAIL
PUBLISHED FOR OPPOSITION
Jun 3, 2003 PUBO
NOTICE OF PUBLICATION
May 14, 2003 NPUB
APPROVED FOR PUB - PRINCIPAL REGISTER
Mar 12, 2003 CNSA
DIVISIONAL PROCESSING COMPLETE
Dec 28, 2002 DPCC
DIVISIONAL REQUEST RECEIVED
Oct 18, 2002 DRRR
PAPER RECEIVED
Oct 18, 2002 MAIL
CORRESPONDENCE RECEIVED IN LAW OFFICE
Oct 18, 2002 CRFA
PAPER RECEIVED
Oct 18, 2002 MAIL
NON-FINAL ACTION MAILED
Jun 17, 2002 CNRT
Sec. 1(B) CLAIM DELETED
May 2, 2002 1.BD
CORRESPONDENCE RECEIVED IN LAW OFFICE
Mar 14, 2002 CRFA
LETTER OF SUSPENSION MAILED
Oct 29, 2001 CNSL
ASSIGNED TO EXAMINER
Oct 24, 2001 DOCK
CORRESPONDENCE RECEIVED IN LAW OFFICE
May 27, 2001 CRFA
NON-FINAL ACTION MAILED
Nov 29, 2000 CNRT
ASSIGNED TO EXAMINER
Nov 24, 2000 DOCK